Lifeboat Foundation

Molecular programs can rescue cells already engaged in the process of apoptosis or other forms of programmed cell death.

While the transhumanism movement is making progress, it isn’t without its skeptics. Some don’t think it will ever work the way we want it to, because it asks science to turn back a natural process of aging that has an uncountable number of manifestations. Critics of anti-aging research envision any number of dystopian futures, in which we defeat many of the causes of death before very old age, leaving only the most ghastly and intractable — but not directly lethal — maladies.

Lest you think this concept is limited to snake-oil salesmen and science-fiction writers, the idea that aging is not inevitable is now in the mainstream of modern medical research at major institutions around the world. The journal Nature dubbed research from the University of California at Los Angeles a “hint that the body’s ‘biological age’ can be reversed.” According to reporting by Scientific American on research at the Salk Institute for Biological Studies: “Aging Is Reversible — at Least in Human Cells and Live Mice.”

Is it accurate?

Does it really show your so-called “biological vs. chronological” age?

And once you do get your results, how can you lengthen your telomeres?

People who live to 110 seem to have unusually high levels of a rare immune cell.

This could be happening to me.

An international research team led by Nanyang Technological University, Singapore (NTU Singapore) has found that microorganisms living in the gut may alter the aging process, which could lead to the development of food-based treatment to slow it down.

All living organisms, including human beings, coexist with a myriad of microbial species living in and on them, and research conducted over the last 20 years has established their important role in nutrition, physiology, metabolism and behavior.

Continue reading “Bacteria in the gut may alter aging process, study finds” »

I HAVE not heard of or seen this Debate-video??? I thought poor Doctor Aubrey de Grey had shot with “escape velocity” let us say past debates about the probability-guarantee of ending aging. Vadim has his beliefs and yet his beliefs are wrong. {As I have stated and have posted memes for many years that state “WHO IN SCIENCE IS CORRECT??? THE SCIENTISTS WHO ARE WRONG OR THE SCIENTISTS WHO ARE RIGHT??? De Grey is correct as am I. I am a mere data researcher solutions analyst {Yet very dedicated.} So with my dedication I have taken the data of Mankind and found all causes of aging and I have found a cure sitting in data.}.

Is comprehensive damage repair feasible? A debate at Undoing Aging 2019 between Vadim Gladyshev, Harvard Medical School and Aubrey de Grey, SENS Research Foundation.

Continue reading “A debate between Vadim Gladyshev and Aubrey de Grey” »

MOUNTAIN VIEW, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) — Underdog Pharmaceuticals, Inc. (Underdog), and SENS Research Foundation (SRF) today announced the launch of Underdog and the completion of its seed round, providing $3.95 million to promote Underdog’s development of disease-modifying treatments for atherosclerosis and other age-related diseases. SRF also announced two senior appointments.

The Underdog round is led by Michael Greve’s Kizoo Technology Capital, part of the Forever Healthy Group and one of the premier organizations focusing on accelerating rejuvenation biotechnologies. It also includes Oculus co-founder Michael Antonov through Tubus, LLC, and financier Harald McPike through Chambray Worldwide, Ltd.

Underdog was built from an SRF flagship program that has driven two years of applied development designed to explore and repair the underlying causes of cardiovascular disease. Its co-founders are Matthew O’Connor, Ph.D. and Michael Kope, formerly the V.P. of Research and the founding CEO, respectively, of SRF.

Summary: Transplanting gut microbiota from older mice to younger germ-free mice increased hippocampal neurogenesis and intestinal growth. Source: Nanyang Technological UniversityAn internationa.

Deep Knowledge Group is delighted to have supported and participated in the landmark International Longevity Policy and Governance and AI for Longevity Summits that took place on November 12th at King’s College London, which gathered an unprecedented density and diversity of speakers and panelists at the intersection of Longevity, AI, Policy and Finance. The summits were organized by Longevity International UK and the AI Longevity Consortium at King’s College London, with the strategic support of Deep Knowledge Group, Aging Analytics Agency, Ageing Research at King’s (ARK) and the Biogerontology Research Foundation. Together they managed to attract the interest of major financial corporations, insurance companies, investment banks, Pharma and Tech corporations, and representatives of international governmental bodies, organisations and embassies, as well as leading media, and featured presentations and panel discussions from top executives and directors of Prudential, Barclays Business UK, HSBC, AXA, L&G, Longevity. Capital, Longevity Vision Fund, Juvenescence, the UK Office of AI, Microsoft, NVIDIA, Babylon Health, Huawei Europe, Insilico Medicine, Longevity International UK, the Longevity AI Consortium and others.

November 14, 2019, London, UK: Deep Knowledge Group executives Dmitry Kaminksiy and Eric Kihlstrom spoke at a landmark one-day event held yesterday at King’s College London with the strategic support Deep Knowledge Group. The event united two Longevity-themed summits under the shared strategic agenda of enabling a paradigm shift from treatment to prevention and from prevention to Precision Health via the synergistic efforts of science, industry, AI, policy and governance, to enable the UK to become an international leader in Healthy Longevity.